SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lovell DJ, Walco GA. Pain associated with juvenile rheumatoid arthritis. Pediatr Clin North Am 1989; 36: 101527.
  • 2
    Schanberg LE, Anthony KK, Gil KM, Maurin EC. Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum 2003; 48: 13907.
  • 3
    Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: CassidyJT, PettyRE, editors. Textbook of pediatric rheumatology. 4th ed. Philadelphia: W.B. Saunders; 2001. p. 218321.
  • 4
    Sherry D, Malleson PN. Idiopathic musculoskeletal pain syndromes. In: CassidyJT, PettyRE, editors. Textbook of pediatric rheumatology. Philadelphia: W.B. Saunders; 2001. p. 38194.
  • 5
    Anthony KK, Schanberg LE. Pain in children with arthritis: a review of the current literature. Arthritis Rheum 2003; 49: 2729.
  • 6
    Kuis W, Heijnen CJ, Hogeweg JA, Sinnema G, Helders PJ. How painful is juvenile chronic arthritis? Arch Dis Child 1997; 77: 4513.
  • 7
    Sawyer MG, Whitham JN, Roberton DM, Taplin JE, Varni JW, Badhurst PA. The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatology (Oxford) 2004; 43: 32530.
  • 8
    Packham JC, Hall MA, Pimm TJ. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. Rheumatology (Oxford) 2002; 41: 14449.
  • 9
    Takken T, van der Net J, Helders PJ. Methotrexate for treating juvenile idiopathic arthritis. Cochrane Database Syst Rev 2001; 4: CD003129.
  • 10
    Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002; 109: 10915.
  • 11
    Jenkins JK, Hardy KJ. Biological modifier therapy for the treatment of rheumatoid arthritis. Am J Med Sci 2002; 323: 197205.
  • 12
    Wilkinson N, Jackson G, Gardner-Medwin J. Biologic therapies for juvenile arthritis. Arch Dis Child 2003; 88: 18691.
  • 13
    Living with rheumatoid arthritis: unmet needs. Arthritis Foundation Newsletter 2004; October.
  • 14
    Katz P. Function, disability, and psychological well-being. Adv Psychosom Med 2004; 25: 4162.
  • 15
    Walco GA, Cassidy RC, Schechter NL. Pain, hurt, and harm: the ethics of pain control in infants and children. N Engl J Med 1994; 331: 5414.
  • 16
    Berde CB, Solodiuk J. Multidisciplinary programs for management of acute and chronic pain in children. In: SchechterNL, BerdeCB, YasterM, editors. Pain in infants, children, and adolescents. 2nd ed. Philadelphia: Lippincott, Williams, and Wilkins; 2003. p. 47186.
  • 17
    Culy CR, Keating GM. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs 2002; 62: 2493537.
  • 18
    Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000: CD000951.
  • 19
    Conn DL, Lim SS. New role for an old friend: prednisone is a disease-modifying agent in early rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 1936.
  • 20
    Simon D, Fernando C, Czernichow P, Prieur AM. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 2002; 29: 1296300.
  • 21
    Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 2003; 88: 197200.
  • 22
    Louie SG, Park B, Yoon H. Biological response modifiers in the management of rheumatoid arthritis [published erratum appears in Am J Health Syst Pharm 2003;60:1095]. Am J Health Syst Pharm 2003; 60: 34655.
  • 23
    Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis: results of a 10-year prospective study. Rheumatology (Oxford) 2001; 40: 90713.
  • 24
    Lehman TJ, Striegel KH, Onel KB. Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis. J Pediatr 2002; 140: 1257.
  • 25
    Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40: 18525.
  • 26
    Schechter NL, Berde CB, Yaster Y. Pain in infants, children, and adolescents: an overview. In: SchechterNL, BerdeCB, YasterM, editors. Pain in infants, children, and adolescents. Philadelphia: Lippincott, Williams and Wilkins; 2003. p. 318.